免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

PubMed

Bridging Early Feasibility and Pivotal Trials: Insights From Transcatheter Tricuspid Valve Interventions.

PMID:42624759 ·

M, o, n, i, c, a, , T, o, c, c, h, i, ;, , E, l, e, o, n, o, r, a, , C, a, p, u, z, z, i, ;, , C, a, r, o, l, i, n, a, , M, a, t, s, u, b, a, y, a, s, h, i, ;, , V, a, l, e, r, i, e, , T, s, e, n, g, -, R, o, g, l, e, r, ;, , V, i, v, i, e, n, n, e, , K, a, y, s, e, r, -, S, o, l, t, y, s, ;, , D, a, r, y, a, , G, h, o, l, a, m, i, ;, , M, a, d, e, l, e, i, n, e, , B, l, a, n, k, e, n, s, p, o, o, r, ;, , N, a, z, i, a, , E, j, a, z, ;, , S, i, l, v, i, a, , R, u, g, g, i, e, r, i, ;, , D, a, v, i, d, e, , D, e, c, a, n, d, i, a, ;, , E, r, i, k, , A, l, v, a, r, a, d, o, ;, , B, r, a, n, d, o, n, , W, i, l, l, i, a, m, s, ;, , M, o, h, a, m, m, e, d, , A, d, i, n, a, n, ;, , P, a, o, l, a, , A, n, t, o, n, i, n, i, ;, , G, i, u, d, i, t, t, a, , C, a, l, l, e, a, ;, , H, e, l, e, n, , B, a, n, k, s

期刊Clinical therapeutics
年份
PMID42624759

摘要

Early feasibility studies (EFS) are critical in the clinical development of high-risk cardiovascular devices, enabling first-in-human evaluation and iterative refinement prior to pivotal investigation. Regulatory frameworks supporting EFS have evolved substantially in the United States (US), while structured European pathways are emerging. This narrative review evaluates the evolution of the US EFS framework and examines its alignment with emerging European initiatives, using transcatheter tricu

官方來源

在 PubMed 上查看 →

資料來自 PubMed / NCBI。全文與最新資訊請一律參閱官方紀錄。

↑